Mingle in Seattle with Genentech, Celgene, OrbiMed, 5AM & More, March 5

Exclusive Event, Powerhouse Lineup: Seattle Cancer Summit

Seattle biotech events don’t get any better than this.

Timmerman Report is bringing together major West Coast players for an intimate half-day event on March 5: the Seattle Cancer Summit. Tickets are limited and going fast. And all proceeds go to the Fred Hutchinson Cancer Research Center, as part of my Everest Climb to Fight Cancer.

We’ll talk about major trends in industrial cancer R&D, hear from entrepreneurs working to fight cancer in unique ways, be inspired by opportunities for startups, and look into the future, including the fascinating role of AI in cancer research.

This is a special moment in time in the fight against cancer. Scientists are more than just chipping away at cancer. They are kicking down the barricades. This summit is a rare chance for 150 people to come together to understand the trends and opportunities in our biotech center.

Register here now, because you don’t want to miss this stellar lineup:


1:00 pm. Registration/networking

1:30 pm Welcome remarks. Niki Robinson, Fred Hutch

1:35 pm. Opening chat:

Rob Hershberg, EVP, head of business development and global alliances, Celgene

Major trends in industrial cancer R&D

James Sabry, SVP, Genentech Partnering

Rob Hershberg, EVP, head of business development, Celgene

Moderator: Andy Schwab, managing partner, 5AM Ventures

2:10 pm.

Emerging company presentations (10 minutes each)

UPDATED PRESENTER: Cliff Stocks, CEO, OncoResponse (antibody drug discovery) 

Colleen Delaney, CMO, Nohla Therapeutics (off the shelf cell therapy for blood cancers)

Joe Victor, CEO, RareCyte (single cell analysis)

Ali Tehrani, CEO, Zymeworks (bispecific antibodies)

2:50 pm

Julie Sunderland, general partner, Biomatics Capital Partners

Cancer biology is moving fast. Where are the big opportunities for startups?

Thong Le, CEO, Accelerator Life Science Partners

Julie Sunderland, managing director, Biomatics Capital

Mitch Gold, executive chairman and CEO, Alpine Immune Sciences

Moderator: Niki Robinson, VP, Fred Hutch

3:30 pm. 


Since this will be a small event with about 150 people, you will have a chance to mix and mingle with the speakers.

4 pm.

What will scientists do with an AI-driven map of antigens and T-cell receptors?

Chad Robins, CEO, Adaptive Biotechnologies

Moderator: Sam Blackman, SVP, Silverback Therapeutics

4:30 pm.

Jay Shendure, professor of genome sciences, UW; director, Brotman Baty Institute

Where is science and industry going in the next five years?

Jay Shendure, professor of Genome Sciences, UW, director of Brotman Baty Institute

Clay Siegall, CEO, Seattle Genetics

Peter Thompson, private equity partner, OrbiMed Advisors

Moderator: Monica Beam, SVP, Alexandria Venture Investments

5:10 pm

A Word on the Everest Climb to Fight Cancer

Before the cocktail hour, I might have a couple minutes for a fun surprise related to my Everest climb.

5:15 pm.


6 pm END


Tickets are limited and going fast. All proceeds go to the Fred Hutchinson Cancer Research Center, as part of my Everest Climb to Fight Cancer.

When & Where

TIME: 1 p.m. to 6 p.m.

DATE: March 5

PLACE: Fred Hutch, Pelton Auditorium, 1100 Fairview Avenue N., Seattle


Advance Registration: $295

At the Door: $350

Sponsors: Thank you

Summit Sponsor:

  • Sanofi

South Col Sponsor:

  • 10X Genomics

Advanced Base Camp Sponsors:

  • Takeda Pharmaceuticals
  • Alexandria Real Estate Equities

Khumbu Icefall Sponsor:

  • Novateur

Base Camp Sponsors:

  • 5AM Ventures
  • Sofinnova Ventures
  • Arch Venture Partners
  • EBD Group
  • Alnylam Pharmaceuticals
  • Loncar Investments



You may also like

When Raising Drug Prices Helps Patients
A Busy IPO Calendar: Forma, Repare, Progenity, Genetron
Beyond CAR-T: New Engineered Immune Cell Types Head to the Clinic
Early Cancer Screening is Maturing. What Will It Mean for Drug Developers?